Recent FDA Auditing Practices and the Top 10 Most Common Cited GMP Deficiencies 2018

Recent FDA Auditing Practices and the Top 10 Most Common Cited GMP Deficiencies 2018 is an event dedicated to the current audit techniques used by FDA and how they have changed over the years.

Recent FDA Auditing Practices and the Top 10 Most Common Cited GMP Deficiencies 2018 covers topics such as:

• Changes in FDA audit approaches
• Increase in FDA enforcement actions
• Most common cited GMP drug deficiencies for 2012-2015
• How best to address FDA 483 observations when received

Recent FDA Auditing Practices and the Top 10 Most Common Cited GMP Deficiencies 2018 intended for:

• Quality Assurance
• Who Will Benefit:
• Manufacturing
• Quality Control
• Regulatory
• Production
• Management
• Laboratory Personnel
• Equipment Vendors